Atara Biotherapeutics

Pharma

Atara, Pierre Fabre hit a hurdle with Ebvallo in the US

The FDA rejected Atara's biologics license application due to "inspection findings" at a facility run by a third-party manufacturer, the biotech said.

Eric Sagonowsky Jan 16, 2025 9:36am

Pierre Fabre commits up to $640M in T-cell deal with Atara

Nov 3, 2023 11:04am

Off-the-shelf T-cell therapy wins world-first approval

Dec 19, 2022 3:22pm

'The Top Line': Pfizer's kickback lawsuit, top vaccine companies

Oct 21, 2022 6:00am

Atara's first-in-class allogeneic T-cell therapy nears EU nod

Oct 14, 2022 11:18am